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Abstract
Objectives To generate system insights on patient and
provider levers and strategies that must be activated to
improve hospital-based smoking cessation treatment.
Design Mixed methods study including a series of indepth group model building sessions, which informed
the design of an online survey completed by healthcare
providers and a structured interview protocol administered
at the bedside to patients who smoke.
Setting Large, tertiary care hospital in the Midwestern
United States.
Participants Group model building: 28 healthcare
providers and 22 previously-hospitalised patients; Online
survey: 308 healthcare providers; Bedside interviews: 205
hospitalised patients.
Primary and secondary outcome measures Hypothesisgenerating, participatory qualitative methods informed the
examination of the following quantitative outcomes: patient
interest versus provider perception of patient interest in
smoking cessation and treatment; patient-reported receipt
versus provider-reported offering of inpatient smoking
cessation interventions; and priority ratings of importance
and feasibility of strategies to improve treatment.
Results System insights included patients frequently
leaving the floor to smoke, which created major workflow
disruption. Leverage points included interventions to
reduce withdrawal symptoms, and action ideas included
nurse-driven protocols for timely administration of nicotine
replacement therapy. Quantitative data corroborated
system insights; for instance, 80% of providers reported
that patients frequently leave the floor to smoke, leading
to safety risks, missed assessments and inefficient use
of staff time. Patients reported significantly lower rates of
receiving any smoking cessation interventions, compared
with provider reports (mean difference=17.4%–33.7%,
p<0.001). Although 92% of providers cited patient interest
as a key barrier, only 4% of patients indicated no interest
in quitting or reducing smoking.
Conclusions Engaging hospital providers and patients in
participatory approaches to develop an implementation
strategy revealed discrepant perceptions of patient interest
and frequency of hospital-based treatment for smoking.
These findings spurred adoption of standardised pointof-care treatment for cigarette smoking, which remains
highly prevalent yet undertreated among hospitalised
patients.

Strengths and limitations
►► Using a systems science lens, this study integrat-

ed multiple data sources to inform more systematic
provision of smoking cessation treatment practices
in hospital settings.
►► This study featured a rigorous mixed methods approach whereby hypothesis-generating qualitative
data informed the design of quantitative instruments
and guided interpretation of resulting quantitative
data.
►► The use of participatory approaches to engage
healthcare provider and patient stakeholders identified provider and patient levers to be activated in a
robust implementation strategy.
►► Despite having many similarities to other healthcare systems in the nation, study findings are based
in one large tertiary care hospital system in the
Midwestern United States.

Introduction
Cigarette smoking remains the leading cause
of preventable death worldwide.1–4 National
efforts directed at reducing tobacco use have
contributed to a decline in the proportion of
combustible cigarette smokers.5 6 However,
smoking prevalence among those entering
hospital settings remains much higher than
in the general population, as those with
chronic conditions have higher prevalence
of smoking.7 8 Hospital settings therefore
present an opportune time to promote cessation.9 10
Despite the existence of effective, Food
and Drug Administration–approved medications for smoking cessation—including
nicotine replacement therapy, varenicline
and bupropion11–13—which can be combined
with brief counselling for optimal success,14
these treatments remain underutilised in
inpatient settings.15–17 In our hospital, only
18%–24% of patients who smoke received
smoking cessation pharmacotherapy during
hospitalisation from 2010 to 2016.8 Further,
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Leverage points to improve smoking
cessation treatment in a large tertiary
care hospital: a systems-based mixed
methods study
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Study purpose
The goal of the study was to understand determinants of
the treatment gap in hospitalised patients who smoke and
inform the development of stakeholder-supported strategies for improving smoking cessation treatment delivery
in the inpatient setting. Building on our robust, validated
electronic health record data demonstrating suboptimal smoking cessation pharmacotherapy prescription
practices,8 this study integrated multiple data sources to
inform more systematic provision of smoking cessation
2

treatment practices in hospital settings. To our knowledge, this is the only study to engage with hospital patients
and providers in a participatory process to identify the
underlying system structure producing the treatment
gap, collateral effects of this gap (eg, impacts on provider
workflow), optimal leverage points and actionable strategies to yield consistent delivery of smoking cessation care
in hospital settings.18–21

Methods
This mixed methods study integrated qualitative and
quantitative data sources including in-depth group
model building sessions with healthcare providers and
patients,21 22 followed by an online survey with healthcare
providers and bedside interviews with patients.
Phase I: group model building with healthcare providers and
patients (qualitative work)
Participants and procedures
Participants were recruited from Barnes-Jewish Hospital
(BJH), a large tertiary care hospital. We engaged two
participant populations1: BJH employees including
physicians, nurses and support staff with patient contact
and2patients who had recently received care at BJH and
who self-identified as current smokers at the time of
their most recent hospital admission. To recruit healthcare providers, we requested programme directors and
nursing supervisors of a diverse set of service lines—
including general surgery, internal medicine, neurology,
oncology, orthopaedics, otolaryngology and psychiatry—to distribute recruitment materials to employees
who may be eligible to participate. We excluded participants from the intensive care unit, emergency room and
operating room due to lower relevance of the topic in
these acute care settings. We also prioritised our active
recruitment efforts within service lines likely to find the
topic most relevant for their service delivery; therefore,
some hospital services (eg, plastic surgery, urology) fell
outside the scope of our recruitment efforts. To recruit
patients who had been previously hospitalised at BJH,
we distributed a recruitment email through a research
participant registry to potentially eligible individuals who
smoke, posted a Facebook advertisement on the registry
fan page listing, and hung printed flyers in the hospital.
Those interested in participating were screened using a
standardised telephone script.
We engaged 50 stakeholders in five group model
building sessions comprised of patients (two sessions,
n=22); nurses, social workers and case managers (one
session, n=14); nurse practitioners, hospitalists and pharmacists (one session, n=6); and resident physicians (one
session, n=8). Using a standard process for synthesising the
models,22–24 we then invited all participants in the initial
sessions to reconvene for a model review that functioned
to present a preliminary synthesis model for critique and
refinement of the stakeholder-generated model (one
session, n=16). Patients and providers stemmed from a
Ramsey AT, et al. BMJ Open 2019;9:e030066. doi:10.1136/bmjopen-2019-030066
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these medications were often prescribed inconsistently
between admitting services and subdemographic groups
in our hospital. For instance, African Americans were
35% less likely than European Americans to receive
smoking cessation pharmacotherapies during their
hospital stay, which highlights concerning inequalities
in hospital prescribing practices.8 Similar patterns were
found in a study of smoking cessation pharmacotherapy
rates among smokers hospitalised for an acute cardiac
condition across 282 US hospitals; the median treatment
rate was 22.3% and even lower among minority racial/
ethnic groups.17 Treatment rates across these hospitals
were also highly variable, suggesting that hospitals may
be using, with varying levels of success, different strategies to implement inpatient smoking cessation treatment
programmes.
These treatment gaps and disparities indicate suboptimal care, as inpatient smoking cessation pharmacotherapy in combination with postdischarge treatment has
been shown in meta-analyses to improve quit rates and
is now considered the standard of care by Joint Commission.10 15 Nevertheless, these treatment gaps and disparities signal that the implementation of smoking cessation
treatment approaches remains a formidable challenge in
hospital settings. Currently, it is not clear which patient
and provider levers and strategies must be activated to
improve smoking cessation treatment in hospital settings.
Additionally, there is inadequate guidance on the best
system-level implementation strategies to use to improve
treatment delivery for hospitalised patients who smoke.
The healthcare system requires pragmatic evidence to
increase the likelihood that other hospitals use strategies
that were robustly supported by rigorous yet relevant data
and decrease the likelihood that hospitals use strategies
without robust support. However, obtaining pragmatic,
rigorous and relevant data may require novel uses of
methods including more participatory, stakeholder-engaged approaches that integrate diverse types of data to
gain a better understanding of the system-level gaps in
care, high-leverage target areas to focus change efforts
and specific strategies that can improve the treatment
of patients who smoke. This study uses a systems science
lens that integrates multiple data sources to inform more
systematic provision of smoking cessation treatment practices in hospital settings, thereby using a novel approach
to address a thorny problem that has challenged healthcare systems for decades.

Open access

Mixed methods analytic approach
We used an exploratory sequential design in which qualitative data from the group model building sessions
informed the design of the quantitative online survey and
patient bedside interviews.25 The qualitative data were
hypothesis generating to further guide the development
of the quantitative measures and interpretation of the
resulting quantitative data.
Phase II: online survey with healthcare providers (quantitative
and qualitative)
Participants and procedures
We recruited healthcare providers to complete an anonymous 10-min online survey by emailing a cover letter and
survey link to administrative contact persons, programme
directors and nursing staff who then distributed the email
through their networks. Participants of the online survey
included 308 providers (112 physicians, 196 nurses)
from BJH with direct inpatient contact. Participants were
located across a wide range of service lines, with internal
medicine (46%) and general surgery (22%) being the
Ramsey AT, et al. BMJ Open 2019;9:e030066. doi:10.1136/bmjopen-2019-030066

most highly represented. As in phase I, we excluded
participants from the intensive care unit, emergency
room and operating room due to lower relevance of the
topic in these acute care settings. Of physicians, 79% were
resident physicians, and 21% were hospitalists. Of nurses,
47% were staff nurses, 30% nurse practitioners and 23%
other types of nurses. Nurses and physicians were asked
via quantitative assessments about their current smoking
cessation treatment practices—namely the use of the
‘5As’: Ask about tobacco use, Advise to quit smoking,
Assess readiness for quit attempt, Assist with medication
and counselling options and Arrange follow-up contact or
referral,26–28 barriers to using these practices, perceived
patient interest in various smoking cessation resources
during an inpatient stay, perceived importance and feasibility of various potential strategies to improve practices
and the frequency of workflow and safety issues related
to hospitalised patient smoking. Qualitative data were
obtained through an open-ended prompt to share ‘final
thoughts or comments on the topic of smoking cessation
treatment at BJH’. The online survey remained open
from late February 2018 to late March 2018.
Phase III: bedside interviews with patients (quantitative)
Participants and procedures
We recruited hospitalised patients to complete a structured 5-min interview at the bedside. Whereas patients
in phase I were recruited subsequent to their hospitalisation as necessary for convening the group model building
sessions, patients recruited in phase III for the brief individualised interviews were still hospitalised yet nearing
discharge. This facilitated accurate recall of events while
minimising the risk of missing patients who had recently
been discharged or delaying patients’ ability to exit the
hospital once discharged. We obtained reports daily
during the month of May 2018 from the hospital electronic
health record to identify potentially eligible patients and
conducted all interviews during this time period. Participants of the bedside interviews included 205 inpatients
who were categorised by electronic health record as
current smokers and nearing hospital discharge. Participants were more often male (56%) and Caucasian (59%),
with a median age of 54 years (M=50.25; SD=15.22). These
demographics appeared to be very similar to those of the
larger population of BJH patients across the hospital who
were current smokers during this time frame (May 2018).
On average, participants smoked 14.0 cigarettes per day
and had stayed in the hospital for 4.5 days within a variety
of admitting services, including internal medicine (38%),
surgery (23%), oncology (13%), cardiology (12%),
neurology (7%) and orthopaedics (5%). Based on an
existing questionnaire to compare patient and provider
reports in a different context,26patients were asked about
their smoking behaviours (ie, verification of current
smoker status prior to hospital admission, cigarettes per
day and frequency of leaving the floor to smoke); ever
and current e-cigarette use; smoking cessation care they
had received during their current inpatient stay (ie,
3
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wide variety of hospital service lines, including cardiology,
general surgery, internal medicine, neurology, obstetrics,
oncology, orthopaedics, otolaryngology and psychiatry.
We received participation from each service line from
which we recruited. Sessions were conducted between
late October 2017 and early February 2018.
Planning, conduct and analysis of the series of sessions
were led by a core modelling team, including the principal investigator, BJH nursing partner and two experts
in group model building and community-based system
dynamics. Each group model building session utilised
a facilitation team, which included the conveners/closers
(principal investigator and nursing partner), primary
modeller (lead expert in group model building), facilitators (approximately two support experts in group model
building) and note takers (approximately two additional
team members). The group model building team used
scripts23 or a pre-defined set of exercises and behaviours
to provide a semistructured environment for1patient
stakeholder groups to model a typical sequence of clinical
encounters that may or may not result in patients being
offered smoking cessation treatment and2 healthcare
provider stakeholder groups to model a typical sequence
of clinical decision points with regard to ordering and
administering smoking cessation treatment and offering
counselling in the hospital. Patient participants were then
asked to identify factors that determine the likelihood of
being offered and receiving smoking cessation treatment.
Similarly, healthcare provider participants were asked to
identify factors that determine the likelihood of offering
smoking cessation pharmacotherapy and counselling, the
likelihood of patients accepting pharmacotherapy and
counselling, sources of decision-making and workflow
barriers. All participants were then asked to prioritise the
identified factors and position them as intervening variables within the modelled sequence of events.

Open access

Statistical analysis approach
Data from the healthcare provider online surveys and
patient bedside interviews were first analysed descriptively
via frequencies and means. Patient-reported receipt of
5As smoking cessation practices was examined in relation
to provider reports using summary independent-sample
t-test analyses. Multiple linear analyses were conducted
to determine associations between medication receipt
and the likelihood and frequency of leaving the floor to
smoke, controlling for cigarettes per day and length of
stay. Missing data across variables were minimal (<2% for
healthcare providers and <3% for patients) and handled
via pairwise deletion.
Patient and public involvement
During participant recruitment, patients were able to
identify other potentially eligible individuals who smoke
to be screened for enrollment. Through the participatory
group model building sessions, patients generated key
system insights that informed the research questions and
outcome measures to be assessed in the subsequent online
survey for healthcare providers and bedside interview
protocol for patients. For instance, patients expressed
significant frustration regarding being asked repeatedly
about their smoking behaviours without being offered
any help to quit smoking during their hospital stay. As a
result, the research team prioritised questions in the quantitative instruments to assess the frequency of patient- and
provider-reported delivery of smoking cessation interventions, as well as patient and provider reports of patient
interest in receiving smoking cessation treatment while
hospitalised. This research reflects a key step in developing a system-level intervention; therefore, patient input
is contributory to ongoing research and practice improvements. We plan to disseminate results of this study to
patients and other participants by presenting findings at
local symposia and conferences that are well attended by
patients, patient advocates, healthcare providers and the
broader community. We will also present these findings
during healthcare provider training workshops, whereby
patients benefit through improved quality of smoking
cessation care in the hospital.

Results
Phase I: group model building
System insights—‘what factors determine the likelihood that
patient smoking will be treated?’
Based on factors prioritised by participants during group
model building, the research team generated a multilevel (ie, individual, hospital, community and policy)
4

understanding, referred to as system insights, that characterised the observed undertreatment of patients who
smoke. Online supplementary file 1 illustrates the intentionally oversimplified backbone structure to which
participants were responding and building on with
content and context. These insights included provider
reports of patients frequently leaving the floor to smoke,
which created major workflow problems and enhanced
provider receptivity to solutions framed to address ‘nicotine withdrawal’ rather than ‘cessation’. A commonly
reported scenario involved untreated hospital patients
going outside to smoke, leading to missed assessments
or procedures, which then prompted nurses to prioritise smoking cessation medications to prevent further
workflow disruptions. Providers also reported a lack of
awareness of resources and enthusiasm balanced with
concerns about time, while patients reported infrequent
receipt of smoking cessation support and preferences for
non-judgemental communication (see table 1).
Potential leverage points—‘what targets could lead to major
system-level improvements?’
With these system insights providing the appropriate
frame, the modelling group then identified potential
leverage points to target for action. Leverage points
refer to places within a complex system in which a small
change can produce large changes in the overall system
behaviour.29 Potential leverage points to address provider-reported insights included interventions framed as
solutions to reduce nicotine withdrawal and subsequent
workflow problems, education and decision support and
a standardised approach to smoking cessation treatment.
Potential leverage points to address patient-reported
insights included transparency of patient interest and use
of treatment and patient-provider rapport through more
supportive cessation messaging (see table 1).
Action ideas—‘which specific strategies appear both highly
important and feasible?’
Finally, stakeholders used these potential leverage points
as the frame for nominating potential concrete solutions
and then prioritising them on perceived importance
and feasibility in the hospital setting. Providers generated action ideas to address their own provider-reported
insights and leverage points, including implementing
nurse-driven protocols for timely administration of inpatient nicotine replacement therapy, using an assortment
of provider training approaches, designing electronic
health records to support point-of-care decisions and
offering point-of-care advice, medication and links to
outpatient counselling. Patients generated action ideas to
address their own patient-reported insights and leverage
points, including creating provider feedback systems,
developing cessation plans for discharge, offering help
to every patient who smokes and revamping hospital
signage for more positive messaging (see table 1). These
system insights, potential leverage points and action
Ramsey AT, et al. BMJ Open 2019;9:e030066. doi:10.1136/bmjopen-2019-030066
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receipt of the 5As: ask, advise, assess, assist and arrange);
interest in quitting smoking now, quitting smoking later,
smoking less, and methods to quit smoking (eg, medications); number of past-year quit attempts; and the importance of various potential strategies to improve practices
(eg, offering medication to every patient who smokes).

Ramsey AT, et al. BMJ Open 2019;9:e030066. doi:10.1136/bmjopen-2019-030066

Enthusiasm to improve inpatient Standardised and coordinated
approach to smoking cessation
smoking cessation is balanced
by concern about demands and treatment
limited time

Patients are often asked about
their smoking but very rarely
assisted with cessation

Patients are more compelled by
positive and non-judgemental
communication

Provider

Patient

Patient

Transparency regarding patient Give providers feedback on individual and
interest in and use of treatment aggregate rates of offering smoking cessation
treatment, as well as patient interest and
engagement with cessation support
Develop cessation plan for discharge
Patient-provider rapport
Ask every patient who smokes if they would
through more supportive
like to help quit smoking
cessation messaging
Revamp hospital signage to incorporate
positive messaging on smoking cessation

‘I’m so tired of being asked if I’m a
smoker without being offered help to
quit. It seems like they are only asking so
that they can check a box and move on’.
(Patient)
‘The more respect staff gives, the more
honest the conversation is, and the
more likely I will be to accept treatment’.
(Patient)

‘Most of us would love to help them quit
smoking, but it is time consuming…
thereby making it feel very much like
extra work and easily dropped when
busy’. (Resident physician)

‘I would like to know more about
free or low-cost smoking cessation
treatment centers to which I can refer
my patients…if there was some way
they could get [medications] at low cost
along with smoking cessation therapy, I
think that would be beneficial’. (Resident
physician)

Use continuing medical education, roving
in-services, quick reference tools, and brief
videos to train providers on how to implement
existing and effective treatments
Design electronic health record modules to
support point-of-care treatment decision

Provide point-of-care brief advice, opt-out
medication and discharge links to community
resources, including quit-line counselling, to
every patient who smokes

‘People go down to smoke and they miss
meds and even appointments which is so
frustrating’. (Staff nurse)

Representative quote

Use nurse-driven protocols to ensure that
readily accessible nicotine replacement
therapy can be provided to inpatients with
little delay

Action ideas
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Provider

Interventions to reduce nicotine
withdrawal symptoms and
framing solutions around
nicotine replacement and
workflow to foster provider
engagement
Education and decision support

Patients frequently leave the floor
to smoke, which creates major
workflow problems; as a result,
providers are more compelled by
‘reducing nicotine withdrawal’
rather than ‘cessation’ efforts
Providers lack awareness of
existing cessation resources to
connect patients at discharge,
which negatively impacts their
willingness to provide inpatient
smoking cessation care

Provider

Potential leverage points

Linking stakeholder-generated system insights with potential leverage points and action ideas

System insights

Table 1

Viewpoint

Open access
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Phase II: healthcare provider online survey
Qualitative data
Open-ended responses from the provider sample were
useful in expanding further on the group model building
data. Key representative quotes are included in table 1 to
reinforce themes from the group model building sessions.
Quantitative data
Rates of smoking cessation practice varied substantially
across the 5As, with the majority of providers indicating
regular completion of Ask (88%), Advise (79%), Assess
(62%) and Assist (63%), with lower rates for Arrange
(24%). Additionally, 64% of providers reported that they
often-to-always encourage the use of medication (eg, nicotine replacement therapy and varenicline) with patients
for smoking cessation.
The most commonly cited barriers to providing treatment were patient lack of interest (92%) and compliance
(92%), followed by lack of awareness of existing community resources for patient referral (72%) and lack of time
(71%).
Approximately 80% of providers reported that patients
often or very often leave the floor to smoke, and this
frequently leads to patients posing a safety risk (75%
reported often or very often), assessments being missed
(51% reported often or very often) and staff time used to
escort patients off the floor (42% reported often or very
often).
The strategies rated as most important for improving
smoking cessation treatment at the hospital were also the
ones rated as most feasible. These top strategies included
asking every patient who smokes if they want help (86%
endorsed as very or extremely important; 77% endorsed
as very or extremely feasible), offering brief advice to
every patient who smokes (65% endorsed as very or
extremely important; 56% endorsed as very or extremely
feasible) and offering medication to every patient who
smokes (62% endorsed as very or extremely important;
52% endorsed as very or extremely feasible).

Table 2 High patient demand to quit smoking
Variables

Patients,
n/N (%)

Interested in quitting now
Interested in quitting now or later

146/200 (73)
188/202 (93)

Interested in quitting now or later or smoking 193/202 (96)
less
Past year quit attempt

118/201 (59)

Ever used e-cigarettes
Currently used e-cigarettes

131/202 (65)
25/202 (12)

6

Figure 1 Providers and patients report discrepant rates of
inpatient smoking cessation treatment.

Phase III: patient bedside interviews
Table 2 highlights high levels of patient smoking cessation
interest and attempts. In particular, nearly three-fourths
(73%) were interested in quitting now, and nearly all
(96%) were interested in quitting or smoking less. Most
patients (59%) had tried quitting in the past year. Nearly
two-thirds (65%) had ever used e-cigarettes, and 12%
currently used them.
Regarding comparisons between patient and provider
reports of the 5As, patients reported rates similar to
providers on Ask (mean difference=−1.4%; p=0.653);
however, they reported much lower rates of receiving
Advise (mean difference=−27.5%; p<0.001), Assess
(mean difference=−33.7%; p<0.001), Assist (mean
difference=−19.2%; p<0.001) and Arrange (mean difference=−17.4%; p<0.001) steps (see figure 1), as well
as being provided with medication to quit smoking
during their inpatient stay (mean difference=−35.0%;
P<0.001; see figure 2). Additionally, in contrast to 92%
of providers citing patient interest as a key barrier to
smoking cessation treatment, only 4% of patients indicated no interest in quitting at some point or smoking
less, and only 27% of patients indicated no interest in
quitting now.
Nearly one-third (31%) of patients reported that they
had left the floor to go smoke during their hospital stay,
and nearly two-thirds of those who left did so multiple
times per day. Overall, receipt of inpatient smoking cessation medication was not significantly associated with
leaving the floor to smoke (p=0.331). However, among
patients who left, those who did not receive smoking
cessation medications were more likely to report leaving
multiple times per day than those who received medications, controlling for cigarettes per day and length of stay
(OR=3.3, p=0.036).
Patients were well-aligned with providers regarding
perceived importance of potential strategies to improve
smoking cessation treatment in the hospital (see figure 3).
The most highly rated strategies were to ask every patient
who smokes if they want help (76% endorsed as very or
extremely important), offer medication to every patient
who smokes (67%) and offer brief advice to every patient
who smokes (58%).
Ramsey AT, et al. BMJ Open 2019;9:e030066. doi:10.1136/bmjopen-2019-030066
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ideas were then examined more closely in the subsequent online survey with providers and bedside interviews with patients.
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Despite high interest, fewer patients receive pharmacologic cessation treatment than indicated by providers.

Discussion
Extensive research has examined the hospital as a prime
setting to engage patients in smoking cessation treatment, as well as effective treatment approaches to employ
in hospital settings,9–14 yet persistent treatment gaps
signal formidable implementation challenges.15–17 This
study uniquely employed a systems science lens to frame
the implementation challenges and opportunities using
a rigorous mixed methods approach to generate system
insights, potential leverage points and specific strategies
to improve the treatment of hospitalised patients who
smoke. Key contributions of this research include (1)
detailing an underutilised participatory, stakeholder-engaged process to yield hypothesis-generating qualitative
data that informed the design and interpretation of quantitative data and (2) a robust set of provider and patient

Figure 3 Potential strategies prioritised by importance and
feasibility among stakeholders.
Ramsey AT, et al. BMJ Open 2019;9:e030066. doi:10.1136/bmjopen-2019-030066

levers to be activated in a multicomponent implementation strategy in future research.
Healthcare providers reported that patient smoking
during a hospitalisation created significant workflow
issues for hospital staff. Despite low current rates of
smoking cessation pharmacotherapy prescribing, we
found high patient demand to quit smoking. Provider-reported barriers centred on a perceived lack of patient
interest, time, and awareness of existing resources; these
barriers reflect aspects of motivation, opportunity, and
capability, which have been identified as key determinants of behavioural change and fruitful targets for intervention.30 31
Despite the wealth of research on inpatient smoking
and hospital-based cessation treatment, far fewer studies
have focused on potential collateral effects of inpatient
smoking and treatment gaps, such as impeded provider
workflow characterised by missed assessments and procedures, misuse of staff time and potential safety concerns,
as found in the current study. Importantly, providers were
much more receptive to and compelled by approaches to
prevent the chain of events involving nicotine withdrawal,
patients leaving the floor to smoke, and workflow problems, as opposed to approaches framed as promoting
smoking cessation among hospitalised patients. This
finding has significant implications for approaches to
engaging hospital providers in the treatment of inpatients who smoke.
Whereas previous research found that nearly one in five
smokers admitted to a hospital smoked cigarettes during
their hospital stay,32 the rate was nearly one in three among
smokers sampled in our hospital setting. Interestingly,
based on patient reports, receipt of nicotine replacement
therapy was not associated with whether or not patients
left the floor to smoke at least once; however, patients
receiving nicotine replacement therapy were more likely
to have only left the floor to smoke once. Therefore, it is
possible that patients may have been receiving nicotine
replacement therapy in response to leaving the floor to
7
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Figure 2
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8

possibility of sampling bias. Finally, patients and providers
from psychiatric services may have different perceptions
about smoking cessation treatment compared with other
patient and provider groups. However, only two participants from psychiatry were included in the exploratory
phase of our study (phase I), and no participants from
psychiatry were included in phases II and III in which we
compared provider and patient reports of treatment (ie,
5As) offering and receipt.
Conclusion
Our findings have led our hospital to adopt standardised,
lighter-touch yet higher-reach approaches to smoking
cessation treatment, supported by provider feedback and
simplified decision support and enabled through the
electronic health record system.9 20 33 34 Prior reviews and
studies frequently highlight the importance of directly
targeting hospital systems, including integrating key
performance indicators into electronic health records, to
improve the delivery of hospital smoking cessation care
and the sustainability of those improvements.35 Despite
the local system changes, the primary contribution of
these findings is in providing generalisable evidence to
help other researchers, providers and hospital administrators to prioritise the use of implementation strategies
that were robustly supported across each phase of our
mixed methods study. The potential leverage points we
identified point to the following specific strategies:
1. Create a standardised and coordinated approach to smoking
cessation treatment: provide point-of-care brief advice,
opt-out medication and discharge links to community
resources, including quit-line counselling, to every patient who smokes.
2. Foster provider engagement by identifying and framing interventions as solutions to reduce nicotine withdrawal and
subsequent workflow problems related to patients leaving the
floor to smoke: use nurse-driven protocols to ensure that
readily accessible nicotine replacement therapy can be
provided to inpatients with little delay.
3. Offer positive, supportive and non-judgemental messaging to
patients: revamp hospital signage to incorporate positive messaging on smoking cessation and focus on
boosting confidence and motivation to quit in patients
who smoke36.
4. Improve awareness, knowledge, self-efficacy and attitudes:
use continuing medical education, roving in-services
and quick reference tools to train providers on existing
and effective treatments and how to implement them.
5. Increase transparency regarding patient interest in and use of
treatment: give providers feedback on ongoing performance and aggregate rates of patient-reported readiness to quit and engagement with quit-line counselling
to foster awareness and accountability.
Engaging hospital stakeholders through a process of
self-identification of approaches to addressable problems
presents opportunities to fit high-leverage challenges with
sustainable, contextually appropriate solutions. Findings
Ramsey AT, et al. BMJ Open 2019;9:e030066. doi:10.1136/bmjopen-2019-030066
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smoke (eg, missing patient prompts the provider to offer
treatment for nicotine withdrawal), thereby reducing the
likelihood that patients subsequently left due to nicotine
withdrawal during their hospital stay. This hypothesis
would require further testing, including an establishment
of temporal precedence to demonstrate the risk of patient
smoking before and after receiving nicotine replacement
therapy in the hospital setting.
Regarding points of (mis)alignment between patient
and provider perceptions, both groups reported high
rates of asking patients whether or not they smoke.
However, patients reported much lower rates of receiving
any smoking cessation support and much higher levels
of interest in cessation, compared with provider reports.
This finding replicates recent research in mental health
settings26 and was corroborated by qualitative data, which
characterised the patient perception that providers
frequently ask about smoking behaviours, yet no actions
result from these inquiries. Improved alignment of
perceptions could benefit patient-provider rapport and
increase acceptance of smoking cessation treatments
when offered—opportunities which were all raised by
patients during group model building discussions.
Finally, patients and providers agreed that the most
important strategies were to ask every patient who smokes
if they want help and offer medication and brief advice
to every patient who smokes. Providers also found these
to be the most feasible potential strategies, despite the
patient reports that these were not frequently occurring.
While seen as feasible, providers may perceive the need
for a hospital-wide programme that expects, supports
and reinforces the practice of offering treatment to
every patient who smokes. As noted in a recent systematic review,31standardised implementation of this type of
opt-out programme that leverages lighter-touch pointof-care support may in fact ease provider burden and
workflow. In addition, the alignment between patients
and providers in ratings of importance and feasibility
give additional credence to the viability of implementing
these proposed strategies in hospital settings.
Limitations of this study include being based in one
large tertiary care hospital system in the Midwestern
United States. However, there are indications that this
hospital system is largely representative of other systems
in the nation. For instance, researchers recently found
smoking cessation medication rates of 22.3% across 282
US hospitals,17 nearly identical to our rate of approximately 22% across years 2010–2016. In addition, patient
recruitment for the group model building sessions was
limited to a research participant registry; as a pool of
patients who are willing to be contacted about research
studies, participants from this registry may differ somewhat from patients at-large. For the online survey, the
link was distributed by the primary contacts of hospital
divisions, and it was not possible to determine how
many healthcare providers received the opportunity to
complete the survey. As a result, we were unable to ascertain response rate and therefore cannot rule out the
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from this study inform engagement with healthcare
provider and patient stakeholders in the development
and implementation of proposed strategies to facilitate
consistent delivery of smoking cessation treatment practices in the hospital setting.

